Does ERTAPENEM Cause Product use in unapproved indication? 346 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 346 reports of Product use in unapproved indication have been filed in association with ERTAPENEM (INVANZ). This represents 8.5% of all adverse event reports for ERTAPENEM.
346
Reports of Product use in unapproved indication with ERTAPENEM
8.5%
of all ERTAPENEM reports
6
Deaths
51
Hospitalizations
How Dangerous Is Product use in unapproved indication From ERTAPENEM?
Of the 346 reports, 6 (1.7%) resulted in death, 51 (14.7%) required hospitalization, and 6 (1.7%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTAPENEM. However, 346 reports have been filed with the FAERS database.
What Other Side Effects Does ERTAPENEM Cause?
Drug ineffective (1,001)
Macular degeneration (776)
Off label use (372)
Pyrexia (279)
Nausea (277)
Confusional state (263)
Pain (255)
Malaise (220)
Weight decreased (220)
Therapeutic product effect incomplete (208)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which ERTAPENEM Alternatives Have Lower Product use in unapproved indication Risk?
ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE
ERTAPENEM vs ERYTHROMYCIN
ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE
ERTAPENEM vs ERYTHROMYCIN LACTOBIONATE
ERTAPENEM vs ERYTHROPOIETIN